Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CDE vs GSK✓SelectedUSD · GSKCDE vs GSK performance historyLatest closeAs of-7.06%11/18
Stock and ETF performance explorer

CDE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+22.5%
GSK return
+100.8%
Excess return
-78.3%
Maximum drawdown
-83.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-7.1%-1.3%-5.7%-6.4%
7D-18.6%-3.1%-15.4%-17.2%
30D-20.2%-0.9%-19.3%-19.9%
3M-33.9%-4.2%-29.7%-32.7%
6M-30.0%-1.6%-28.4%-30.4%
YTD-31.3%+2.6%-33.9%-33.6%
1Y-14.8%+6.2%-21.0%-19.4%
3Y+386.3%+55.0%+331.3%+240.6%
5Y+84.8%+42.8%+42.0%+34.2%
All+22.5%+100.8%-78.3%-34.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling